Although some studies reported that high levels of CD44 expression was associated with a poor prognosis in ovarian cancer patients [17, 28], On the contrary, other groups concluded that CD44 expression had no influence on the survival of patients with ovarian cancer [15, 27]. This evidence concerns the gene CD44 and ovarian carcinoma.